Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis

Gastrointestinal Endoscopy

Volumn 79, Issue 3, 2014, Pages 455-465

  Konijeti, Gauree Gupta ^a   Shrime, Mark G ^b   Ananthakrishnan, Ashwin N ^a   Chan, Andrew T ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; AGED; BENCHMARKING; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INDIANA; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84893877421     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2013.10.026     Document Type: Article

References (46)

1. F.A. Farraye, R.D. Odze, and J. Eaden et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology 138 2010 738 745
2. G.C. Nguyen, K.D. Frick, and T. Dassopoulos Medical decision analysis for the management of unifocal, flat, low-grade dysplasia in ulcerative colitis Gastrointest Endosc 69 2009 1299 1310
3. L.J. Herrinton, L. Liu, and T.R. Levin et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010 Gastroenterology 143 2012 382 389
4. T. Jess, C. Rungoe, and L. Peyrin-Biroulet Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies Clin Gastroenterol Hepatol 10 2012 639 645
5. T. Jess, J. Simonsen, and K.T. Jorgensen et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years Gastroenterology 143 2012 375 381
6. T.A. Ullman Should chromoendoscopy be the standard of care in ulcerative colitis dysplasia surveillance? Gastroenterol Hepatol (NY) 6 2010 616 620
7. J.H. Rubenstein, A.K. Waljee, and J.M. Jeter et al. Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates Am J Gastroenterol 104 2009 2222 2232
8. J.A. Eaden, K.R. Abrams, and J.F. Mayberry The risk of colorectal cancer in ulcerative colitis: a meta-analysis Gut 48 2001 526 535 (Pubitemid 32234798)
9. F. Delco, and A. Sonnenberg A decision analysis of surveillance for colorectal cancer in ulcerative colitis Gut 46 2000 500 506 (Pubitemid 30305814)
10. V. Subramanian, J. Mannath, and K. Ragunath et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease Aliment Pharmacol Ther 33 2011 304 312
11. L. Wu, P. Li, and J. Wu et al. The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials Colorectal Dis 14 2012 416 420
12. S.R. Gorfine, J.J. Bauer, and M.T. Harris et al. Dysplasia complicating chronic ulcerative colitis: Is immediate colectomy warranted? Dis Colon Rectum 43 2000 1575 1581
13. C.E. Rubin, R.C. Haggitt, and G.C. Burmer et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis Gastroenterology 103 1992 1611 1620
14. D.T. Rubin, J.A. Rothe, and J.T. Hetzel et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 65 2007 998 1004 (Pubitemid 46770732)
15. T. Matsumoto, Y. Iwao, and M. Igarashi et al. Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis Inflamm Bowel Dis 14 2008 259 264 (Pubitemid 351288049)
16. F.J. van den Broek, P. Fockens, and S. van Eeden et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis Endoscopy 43 2011 108 115
17. J.B. Kisiel, E.V., Loftus Jr., and W.S. Harmsen et al. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy Inflamm Bowel Dis 18 2012 226 235
18. M.D. Rutter, B.P. Saunders, and K.H. Wilkinson et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis Gastroenterology 130 2006 1030 1038
19. C.A. Siegel, L.M. Schwartz, and S. Woloshin et al. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations Inflamm Bowel Dis 16 2010 1658 1662
20. P.J. Pickhardt, J.R. Choi, and I. Hwang et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults N Engl J Med 349 2003 2191 2200 (Pubitemid 37485135)
21. J.E. Siegel, M.C. Weinstein, and L.B. Russell et al. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine JAMA 276 1996 1339 1341 (Pubitemid 26346934)
22. M.C. Weinstein, J.E. Siegel, and M.R. Gold et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine JAMA 276 1996 1253 1258 (Pubitemid 26337709)
23. D. Kottachchi, D. Yung, and J.K. Marshall Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital Can J Gastroenterol 23 2009 613 617
24. A. Vienne, T. Simon, and J. Cosnes et al. Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort Aliment Pharmacol Ther 34 2011 188 195
25. A. Kohn, V. Fano, and R. Monterubbianesi et al. Surgical and nonsurgical hospitalization rates and charges for patients with ulcerative colitis in Italy: a 10-year cohort study Dig Liver Dis 44 2012 369 374
26. S.D. Holubar, K.H. Long, and E.V., Loftus Jr. et al. Long-term direct costs before and after proctocolectomy for ulcerative colitis: a population-based study in Olmsted County, Minnesota Dis Colon Rectum 52 2009 1815 1823
27. S. de Silva, C. Ma, and M.C. Proulx et al. Postoperative complications and mortality following colectomy for ulcerative colitis Clin Gastroenterol Hepatol 9 2011 972 980
28. E.B. Schneider, O. Hyder, and B.S. Brooke et al. Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors J Am Coll Surg 214 2012 390 398 discussion 8-9
29. D.A. Fisher, J.T. Maple, and T. Ben-Menachem et al. Complications of colonoscopy Gastrointest Endosc 74 2011 745 752
30. A.J. Muir, L.J. Edwards, and L.L. Sanders et al. A prospective evaluation of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis Am J Gastroenterol 96 2001 1480 1485 (Pubitemid 32455078)
31. R.M. Ness, A.M. Holmes, and R. Klein et al. Utility valuations for outcome states of colorectal cancer Am J Gastroenterol 94 1999 1650 1657 (Pubitemid 29260460)
32. H.H. Tsai, Y.S. Punekar, and J. Morris et al. A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis Aliment Pharmacol Ther 28 2008 1230 1239
33. C. Gunnarsson, J. Chen, and J.A. Rizzo et al. Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey Dig Dis Sci 57 2012 3080 3091
34. K. Lang, L.M. Lines, and D.W. Lee et al. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data Clin Gastroenterol Hepatol 7 2009 198 204
35. A.B. Mariotto, K.R. Yabroff, and Y. Shao et al. Projections of the cost of cancer care in the United States: 2010-2020 J Natl Cancer Inst 103 2011 117 128
36. L.M. Wong Kee Song, D.G. Adler, and B. Chand et al. Chromoendoscopy Gastrointest Endosc 66 2007 639 649 (Pubitemid 47464263)
37. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, November 2011 SEER data submission, posted to the SEER Web site, April 2012. Accessed August 24, 2012.
38. C.N. Bernstein, F. Shanahan, and W.M. Weinstein Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343 1994 71 74 (Pubitemid 24019346)
39. C. Hassan, P.J. Pickhardt, and A. Zullo et al. Cost-effectiveness of early colonoscopy surveillance after cancer resection Dig Liver Dis 41 2009 881 885
40. K. Hata, T. Watanabe, and S. Kazama et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population Br J Cancer 89 2003 1232 1236 (Pubitemid 37363409)
41. T. Jess, E.V., Loftus Jr., and F.S. Velayos et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota Inflamm Bowel Dis 12 2006 669 676 (Pubitemid 44253749)
42. T. Ullman, V. Croog, and N. Harpaz et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis Gastroenterology 125 2003 1311 1319 (Pubitemid 37409751)
43. S.D. Grosse Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold Expert Rev Pharmacoecon Outcomes Res 8 2008 165 178 (Pubitemid 351959547)
44. D.A. Lieberman, D.K. Rex, and S.J. Winawer et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer Gastroenterology 143 2012 844 857
45. U. Gunther, D. Kusch, and F. Heller et al. Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols Int J Colorect Dis 26 2011 667 672
46. M. Pellise, M. Lopez-Ceron, and C. Rodriguez de Miguel et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study Gastrointest Endosc 74 2011 840 848